Skip to content
Clinical Trials – home
CzechiaBack to Czechia

Clinical trials in Nachod – page 4

52 clinical trials in Nachod, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.

CzechiaOur site in CzechiaKlinickeTesty.cz(opens in a new tab)
Nachod at a glance
52
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

52 trials in Nachod

Open in trial search

Arteriosclerosis

Not recruiting
Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Inclisiran
  • Sponsor:Novartis Pharma AG

Hypertriglyceridaemia

Not recruiting
Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Bio89-100
  • Sponsor:89bio Inc.
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Eyepoint Inc.
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S

Dermatitis atopic

Not recruiting
Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Rocatinlimab
  • Sponsor:Amgen Inc.
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Eye103
  • Sponsor:Eyebiotech Limited
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Eyepoint Inc.

Type 2 diabetes mellitus+1

Not recruiting
Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:BI 456906
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Insulin Glargine
  • Sponsor:Novo Nordisk A/S

Hypertriglyceridaemia

Not recruiting
Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
  • Sponsor:Arrowhead Pharmaceuticals Inc.
Countries:CzechiaCzechia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Sponsor:Pfizer Inc.

Other cities in Czechia

The busiest research cities in the country

All 158 cities in Czechia

Clinical research in Nachod

What the registry says about research in the country

01 Metabolic & Cardiovascular Research

Clinical trials focusing on hypertriglyceridemia and cardiovascular health, evaluating innovative treatments for managing lipid levels and preventing adverse cardiovascular events.

  • Severe Hypertriglyceridemia Treatment
  • Cardiovascular Disease Prevention
  • Type 2 Diabetes Management

Multiple studies are testing new compounds like plozasiran and olezarsen for triglyceride reduction.

02 Dermatological Studies

Comprehensive research into chronic skin conditions, with emphasis on plaque psoriasis and atopic dermatitis treatments.

  • Moderate to Severe Psoriasis
  • Atopic Dermatitis
  • Alopecia Areata

Studies evaluate long-term safety and efficacy of novel therapeutic agents for persistent skin conditions.

03 Chronic Disease Management

Investigations into treatments for chronic kidney disease and heart failure, with particular focus on combination therapies.

  • Heart Failure with Reduced Ejection Fraction
  • CKD with Hypertension
  • Obesity Management

Research includes innovative approaches to managing complex chronic conditions and their complications.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.